Weekly Roundup: August 23-27

ICYMI, some of this week’s featured content includes the ACP encouraging all vaccinations, video interviews diet and supplement in psoriasis treatment, articles on safety, efficacy study results for abrocitinib, SCALE conference coverage and more.

POLL: Are you reevaluating your office's health and safety protocols?

ACP Encourages Americans to Get Vaccinated Against Preventable Diseases – Not Just COVID-19

An expected rise in COVID-19 cases in combination with other preventable diseases could overwhelm the healthcare system.

Abrocitinib and Topical Therapy Safe, Effective for Atopic Dermatitis in Teens

A phase 3 trial studied the effectiveness of oral abrocitinib along with topical therapy for moderate-to-severe atopic dermatitis in teens.

Understanding Type 2 Inflammation

In this video interview, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

Study: Curcumin Nanoparticles as a Photoprotective Adjuvant

Curcumin has a long history as an effective treatment for everything from chronic pain to skin infections. Nanoparticle encapsulation shows promise in meeting that challenge and opening the way for a safe, effective adjuvant to sunscreen.

Estrogen and Its Role in Skin Care

A study published in the Dermatol Ther (Heidelb) journal performed an investigational overview on estrogens and their impact on health while explaining how this leads to cosmeceuticals for female patients with estrogen-deficient skin.

Number of Physician-owned Private Practices Saw Major Decline Since 2018

The share of physicians in private practice has dropped below 50 percent.

Bimekizumab Effective for Hidradenitis Suppurativa

Though investigators called for more research on the biologic, recent data showed patients treated with bimekizumab recorded improved skin pain when compared to placebo and adalimumab.

Bimekizumab Approved by EC

UCB announced the European Commission have granted marketing authorization for bimekizumab for the treatment of moderate to severe plaque psoriasis.

SRT Shows Positive Outcomes for NMSC

Part 1 of Dermatology Times®’ coverage of a strategic look at superficial radiation therapy (SRT) presented at the recent Music City SCALE Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting in Nashville, Tennessee, showcases this therapy’s efficacy in treating keratinocytic skin cancers.

Combination Therapies with Monica Bonakdar, MD

In this video interview, Monica Bonakdar, MD, shares her thoughts on combination therapies, how COVID-19 affected her practice, and more.

Immunotherapy Helps Manage Skin Disease in Patients with Cancer

There are an increasing number of novel immunotherapies available for patients with skin cancer, however, their numerous adverse events must be addressed.

Upadacitinib Approved in EU for Atopic Dermatitis

Upadacitinib has been approved by the European Commision and becomes the first Janus kinase (JAK) inhibitor approved in the European Union for the treatment of moderate to severe atopic dermatitis in adult and pediatric patients.

Comparing Pediatric and Adult Hidradenitis Suppurativa Patients

Many conditions are different in the pediatric population than in the adult population. How does hidradenitis suppurativa differ between the 2 groups?

Curcumin Shows Promise as New Sunscreen Filter

It has been 20 years since the FDA approved a new sunscreen filter. However, a recent study evaluating curcumin could change that.

Preventing Keloid Recurrence With SRT

Part 2 of Dermatology Times®’ coverage of a strategic look at superficial radiation therapy (SRT) presented at the recent Music City SCALE Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting details this therapy’s potential for reducing keloid recurrence.

Delta Variant Hindering Hospital, Physician Group Recovery

A jump in new COVID-19 cases dropped margins and volumes.

U.S. Spent Over $2 Billion on COVID-19 Hospitalization Costs for Unvaccinated

185,000 adults with confirmed cases of COVID-19 were hospitalized in June and July. Of those, 182,000, or 98.3%, had not been vaccinated for the disease.